Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-18

Clinical Trial Update: The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study evaluating dapagliflozin in combination with insulin in Japanese subjects with Type 1 diabetes mellitus. The r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2019-01-18